We've found
439
archived clinical trials in
Eating Disorder
We've found
439
archived clinical trials in
Eating Disorder
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Dasotraline Binge Eating Disorder Study
Updated: 9/20/2017
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Click here to add this to my saved trials

Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
Updated: 10/17/2017
Atypical Antipsychotic Medication in Anorexia Nervosa
Status: Enrolling
Updated: 10/17/2017
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
Updated: 10/17/2017
Atypical Antipsychotic Medication in Anorexia Nervosa
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials

The Effects of Yoga on Body Image in College Women
Updated: 10/26/2017
Can Yoga Reduce Body Image Concerns in Females, Thereby Reducing Risk of Obesity and Eating Disorders?
Status: Enrolling
Updated: 10/26/2017
The Effects of Yoga on Body Image in College Women
Updated: 10/26/2017
Can Yoga Reduce Body Image Concerns in Females, Thereby Reducing Risk of Obesity and Eating Disorders?
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Updated: 11/21/2017
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Status: Enrolling
Updated: 11/21/2017
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Updated: 11/21/2017
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
Updated: 12/11/2017
Fluoxetine After Weight Restoration in Anorexia Nervosa
Status: Enrolling
Updated: 12/11/2017
Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
Updated: 12/11/2017
Fluoxetine After Weight Restoration in Anorexia Nervosa
Status: Enrolling
Updated: 12/11/2017
Click here to add this to my saved trials

Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Updated: 12/20/2017
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Status: Enrolling
Updated: 12/20/2017
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Updated: 12/20/2017
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials

Testing an Alternative Therapy for Bulimia Nervosa
Updated: 3/27/2018
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
Testing an Alternative Therapy for Bulimia Nervosa
Updated: 3/27/2018
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials

Testing an Alternative Therapy for Bulimia Nervosa
Updated: 3/27/2018
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
Testing an Alternative Therapy for Bulimia Nervosa
Updated: 3/27/2018
Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials

Psychosocial Issues and Bariatric Surgery
Updated: 3/27/2018
Psychosocial Issues and Bariatric Surgery
Status: Enrolling
Updated: 3/27/2018
Psychosocial Issues and Bariatric Surgery
Updated: 3/27/2018
Psychosocial Issues and Bariatric Surgery
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials

Efficacy of the Female Athlete Body Project (FAB)
Updated: 4/3/2018
Healthy Weight Intervention in Female Athletes: A Randomized Controlled Trial
Status: Enrolling
Updated: 4/3/2018
Efficacy of the Female Athlete Body Project (FAB)
Updated: 4/3/2018
Healthy Weight Intervention in Female Athletes: A Randomized Controlled Trial
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials

Stepped Care Treatment for Binge-Eating
Updated: 4/18/2018
Dialectical Behavior Therapy for Early Non-Responders to CBT
Status: Enrolling
Updated: 4/18/2018
Stepped Care Treatment for Binge-Eating
Updated: 4/18/2018
Dialectical Behavior Therapy for Early Non-Responders to CBT
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials

Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Click here to add this to my saved trials

Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Click here to add this to my saved trials

Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Updated: 5/1/2018
Eating Disorders Programs: An Indicated Trial
Status: Enrolling
Updated: 5/1/2018
Click here to add this to my saved trials
